USA v. Babich et al

  1. December 03, 2018

    Atty Fighting Sanctions Says Lies Ignored In Insys Case

    An attorney for the billionaire founder of Insys Therapeutics filed documents in Boston federal court Monday to suggest that prosecutors believed a then-suspect who is now cooperating with prosecutors in the company's bribery case was lying to them in a 2016 proffer, but chose not to prosecute him for the lies.

  2. November 30, 2018

    Gov't Wants Insys Founder's Atty Sanctioned For Media Talk

    Prosecutors on Thursday asked a Boston federal judge to sanction the attorney for billionaire Insys Therapeutics founder John Kapoor, saying comments she made to the press were meant to "attack the credibility and testimony" of a co-defendant who recently pled guilty and agreed to cooperate with the government.

  3. November 29, 2018

    Insys Founder Must Turn Over Docs In Opioid Probe, Feds Say

    The billionaire founder and former chairman of Insys Therapeutics Inc. cannot withhold company documents from federal prosecutors seeking to prove a conspiracy to bribe doctors to prescribe fentanyl-based drugs just because he happens to be in possession of them, the government said Thursday.

  4. November 28, 2018

    Insys Ex-VP To Cooperate With Gov't In Opioid Kickback Case

    The former vice president of sales at Insys Therapeutics pled guilty to racketeering conspiracy in Boston federal court Wednesday, saying he would help prosecutors in their case against his bosses and subordinates for allegedly bribing doctors to prescribe dangerous fentanyl-based painkillers.

  5. November 15, 2018

    Insys Sales VP To Plead Guilty In Opioid Kickback Case

    A major player in an alleged conspiracy to bribe doctors to prescribe fentanyl-based drugs from the company Insys Therapeutics is prepared to plead guilty, prosecutors said Wednesday in a filing in Boston federal court.

  6. September 26, 2018

    Doctor DQ'd From Testifying About Opioids In Insys Case

    A Massachusetts federal judge on Wednesday disqualified an expert on pain management and opioids from testifying at the 2019 racketeering trial of former executives at drugmaker Insys Therapeutics Inc., whose counsel at Wilkinson Walsh Eskovitz LLP accused the expert of double-crossing them.

  7. August 24, 2018

    Ex-Insys Execs Press Gov't For RICO Indictment Details

    A group of former Insys Therapeutics Inc. executives say they are tired of waiting around for the federal government to specify and explain the Racketeer Influenced and Corrupt Organizations Act indictment they face, telling a Massachusetts judge on Friday that she should set a deadline for a bill of particulars as the winter trial date looms.

  8. August 21, 2018

    Feds Ordered To Hand Over Insys Docs From 10 Agencies

    A Massachusetts magistrate judge ordered federal prosecutors in Boston on Tuesday to hand over any documents from 10 federal agencies' investigations of opioid manufacturer Insys Therapeutics Inc. that could potentially help the company's former executives fight racketeering and fraud charges.

  9. August 20, 2018

    Insys Execs Say Expert Witness Switched Sides

    The founder and former top executives at opioid manufacturer Insys Therapeutics Inc. told a Massachusetts federal judge Monday that they were double-crossed by a doctor who plans to testify against them in the government's racketeering case in an alleged scheme to bribe doctors to prescribe a fentanyl spray.

  10. July 27, 2018

    Ex-Insys Execs Say Feds' Bid To Redo RICO Case Is Futile

    A group of former Insys Therapeutics Inc. executives told a Massachusetts federal judge Friday that a recent government bid to clarify the racketeering charges they face for allegedly bribing doctors to prescribe their expensive fentanyl spray comes up short of the legal standard, and another trip to the grand jury will not fix the indictment's flaws.